|
About Us |
Technology |
Markets |
News |
Contact Us |
Newsroom |
Archives: |
|
|
|
|
|
To receive our press releases and other announcements by e-mail, please send us a request at |
|
August 2004 |
Affinergy, Inc. |
Affinergy Secures More Than $2 Million in Investments to Commercialize Coatings MCNC, Trinity Healthcare, Charleston Angel Partners, Wilmington Investor Network and numerous individuals participate in larger than expected funding round. -- more... |
|
August 2004 |
Affinergy, Inc. |
Affinergy Selected to Receive $150,000 Loan from North Carolina Biotechnology Center Funds expected to accelerate development and optimization of Affinergy coatings designed to reduce infections related to catheters. -- more... |
|
August 2004 |
Affinergy, Inc. |
Affinergy Recruits Two Senior Executives to Lead Research & Development Proven Leaders in Microbiology and Protein Chemistry to accelerate commercialization of Affinergy's platform coating technology. -- more... |
|
June 2004 |
Affinergy, Inc. |
Affinergy Selects Hyman, Phelps & McNamara, P.C.
as Regulatory Counsel for its Platform Coatings Technology Experienced FDA device experts to assist Affinergy in Clinical and Regulatory Strategy. -- more... |
|
April 2004 |
Affinergy, Inc. |
Affinergy to Add Medical Device Experts, Proven Entrepreneurs, and Experienced Investors to its Board of Directors in Conjunction with Initial $1 Million of Investment New directors bring expertise in medical device commercialization, business development, strategy, and corporate partnering. -- more... |
|
March 2004 |
"The Gray Sheet" |
Affinergy Exploring BMP Applications for IFBM Device Coating Process Affinergy's plan to license its Interfacial Biomaterial (IFBM) coating process will allow the start-up to avoid the costs of bringing a combination product to market. -- more... |
|
March 2004 |
The Science Advisory Board |
BioEntrepreneur Series: Translating Discoveries Into Medical Technology Dr. Daniel Kenan's motivation in co-founding Affinergy was to translate his discoveries in vascular biology into technology that directly helps patients. -- more... |
|
February 2004 |
Affinergy, Inc. |
Affinergy Secures Exclusive Worldwide License to Duke University's Interfacial Biomaterials Patent and Proprietary Coating Materials Platform coatings technology to be commercialized in wide range of industries, including medical devices, filtration, diagnostics, and biosensors. -- more... |
|
January 2004 |
Affinergy, Inc. |
Affinergy Chosen to Present to Medical Device Companies at "Investment In Innovation" (In3) Conference Unique coatings technology to be described at national showcase of emerging medical device companies. -- more... |
|
January 2004 |
Affinergy, Inc. |
Affinergy Selected to Present its Platform Technology at Venture 2004 Conference Advanced coatings technology to be showcased at the southeast's premiere investor conference. -- more... |